Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials. Built with ResearchKit, the FocalView app looks to improve data captured by allowing patients interested in participating to conveniently self-report their conditions through their smartphone, thereby providing researchers with a greater wealth of time-stamped data.
from MobiHealthNews https://ift.tt/2FlDOJk
April 27, 2018
Rose
MobiHealthNews
No comments
Related Posts:
J&J gets $2.1B offer to sell Lifescan glucometer businessPlatinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-ba… Read More
Parachute Health raises $5.5M to digitize 'archaic' medical equipment ordersNew York-based Parachute Health — a startup looking to digitize the ordering of durable medical equipment (DME) and other critical medical equipment for patients leaving the hospital — told MobiHealthNews that it has secured … Read More
Finnish university develops hardware-free smartphone a-fib detectorA smartphone app developed the University of Turku, Finland, detected Turku University Hospital patients’ atrial fibrillation with 96 percent accuracy, without the need for additional phone attachments, according to a study r… Read More
Reports: Google Fit is coming to iOSYesterday, Google announced in a blog post that Android Wear was changing its name to Wear OS, a rebranding designed to reflect the fact that one in three Android Wear users also uses an iPhone. The company hopes to make it m… Read More
Health management app Oneview Connect deployed in Sydney Children’s Hospital NetworkHealthcare management and communication platform Oneview has recently announced that it will be deploying its new app, Oneview Connect, at Sydney Children’s Hospital Network, which is the largest network of hospitals and serv… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment